Intranasal dexmedetomidine for sedation in children undergoing echocardiography study: a Prospective observational study

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-ONC-14004250

Enrollment

Unknown

Registered

2014-01-09

Start date

2013-05-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

congenital heart disease

Interventions

Case series:intranasal dexmedetomidine

Eligibility

Sex/Gender

All

Age

No minimum to 3 Years

Inclusion criteria

Inclusion criteria: Children of ASA physical status I-II, aged between 0 and 36 months, scheduled to undergo echocardiography examination will be enrolled.

Exclusion criteria

Exclusion criteria: Exclusion criteria include known allergy or hypersensitive reaction to dexmedetomidine, organ dysfunction and mental retardation.

Design outcomes

Primary

Measure	Time frame
Onset time;wake up time;mOAAS’s score;	—

Secondary

Measure	Time frame
duration of procedure;HR;SPO2;blood pressure;	—

Countries

China

Contacts

Public ContactLi Bilian

Guangzhou Women and Children's Medical Centre

13570226780@126.com+86 13570226780

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026